{"id":"https://genegraph.clinicalgenome.org/r/105da347-bede-4bab-9161-d9bde7eb8979v2.2","type":"EvidenceStrengthAssertion","dc:description":["*COL2A1* was first reported in relation to autosomal dominant Stickler syndrome type 1 in 1987 (Francomano et al., PMID: 2896625). Stickler syndrome is characterized by ocular, auditory, skeletal, and orofacial abnormalities. Most forms are identifiable by findings in the eye including high myopia, vitreoretinal degeneration, retinal detachment, and cataracts (Baker et al., PMID: 21671392). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in molecular mechanisms and phenotypic variability. Therefore, the following disease entities have been split into multiple disease entities, *COL2A1*-related spondyloepiphyseal dysplasia (OMIM:609162, OMIM:183900, OMIM:184254, OMIM:184250), dysplasia of the proximal femoral epiphyses (OMIM:608805, OMIM:150600), spondyloperipheral dysplasia (OMIM:271700), Stickler syndrome type 1 (OMIM:108300), Kniest dysplasia (OMIM:156550), Achondrogenesis type II (OMIM:200610), and platyspondylic skeletal dysplasia, Torrance type (OMIM:151210). The split curations have been curated separately. 10 variants (missense, nonsense, and frameshift) that have been reported in 10 probands in 7 publications (PMIDs: 1677770, 17721977, 26626311, 27408751, 31736238, 8434604, 8737653) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease association is also supported by experimental evidence (animal models and expression studies) (PMIDs: 12525971, 16546167, 3033664, 7806485). *COL2A1* is expressed throughout the skeletal structure as well as throughout the eye, with expression in the vitreous space and the ganglion cell layer of the retina being most relevant to the most common phenotypes seen in patients. In summary, *COL2A1* is definitively associated with autosomal dominant Stickler syndrome type 1. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the Skeletal Disorders Gene Curation Expert Panel on 2/7/22 (SOP version 9).","*COL2A1* was first reported in relation to autosomal dominant Stickler syndrome type 1 in 1987 (Francomano et al., PMID: 2896625). Stickler syndrome is characterized by ocular, auditory, skeletal, and orofacial abnormalities. Most forms are identifiable by findings in the eye including high myopia, vitreoretinal degeneration, retinal detachment, and cataracts (Baker et al., PMID: 21671392). 10 variants (missense, nonsense, and frameshift) that have been reported in 10 probands in 7 publications (PMIDs: 1677770, 17721977, 26626311, 27408751, 31736238, 8434604, 8737653) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. Notably, *COL2A1* has been definitively associated with Achondrogenesis type 2-hypochondrogenesis, Platyspondylic dysplasia, Spondyloepiphyseal dysplasia congenita, Kniest dysplasia, and spondyloperipheral dysplasia as well as moderately with SED with metatarsal shortening (Czech Dysplasia) after curation by the ClinGen Skeletal Disorders GCEP. This gene has also been associated with Dysplasia of the proximal femoral epiphyses (PMID: 31633310), which will be assessed separately. The mechanism of pathogenicity is known to be loss of function. This gene-disease association is also supported by experimental evidence (animal models and expression studies) (PMIDs: 12525971, 16546167, 3033664, 7806485). *COL2A1* is expressed throughout the skeletal structure as well as throughout the eye, with expression in the vitreous space and the ganglion cell layer of the retina being most relevant to the most common phenotypes seen in patients. In summary, *COL2A1* is definitively associated with autosomal dominant Stickler syndrome type 1. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the Skeletal Disorders Gene Curation Expert Panel on 2/7/22 (SOP version 9)."],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/105da347-bede-4bab-9161-d9bde7eb8979","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3eb9287e-d731-417e-a814-9630b47301a4","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3eb9287e-d731-417e-a814-9630b47301a4_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":["2023-09-28T16:00:00.000Z","2023-09-28T04:00:00.000Z"],"role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/3eb9287e-d731-417e-a814-9630b47301a4_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2025-05-16T17:39:57.702Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3eb9287e-d731-417e-a814-9630b47301a4_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b81b71c-cb3b-4bf0-b601-c893da7637c9","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b81b71c-cb3b-4bf0-b601-c893da7637c9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26626311","allele":{"id":"https://genegraph.clinicalgenome.org/r/f4236c36-9df5-458e-a8b1-fad6d3d0926d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001844.5(COL2A1):c.2353C>T (p.Arg785Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10605488"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/34abbcf2-2884-4a11-8e93-051a64b99363","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/34abbcf2-2884-4a11-8e93-051a64b99363_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1677770","allele":{"id":"https://genegraph.clinicalgenome.org/r/c3d2aaa0-60a6-4ced-a658-c6b88e116b3d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001844.5(COL2A1):c.2794C>T (p.Arg932Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA281739"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/78e2520f-72d7-400a-909e-b82e5a9092d4","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78e2520f-72d7-400a-909e-b82e5a9092d4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27408751","allele":{"id":"https://genegraph.clinicalgenome.org/r/c5c51bdf-145a-4bbf-a0e5-935e93745c59","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001844.5(COL2A1):c.237del (p.Ile80SerfsTer37)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573102924"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/6c23df21-2b02-41d0-8c6e-b7a09099f31b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c23df21-2b02-41d0-8c6e-b7a09099f31b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8434604","allele":{"id":"https://genegraph.clinicalgenome.org/r/7fd30e02-fedd-4f70-93e6-0cf29456061c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001844.5(COL2A1):c.625C>T (p.Arg209Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA281742"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2d253cc7-dd42-47bc-a737-812a9e8b6e6e","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d253cc7-dd42-47bc-a737-812a9e8b6e6e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27408751","allele":{"id":"https://genegraph.clinicalgenome.org/r/f58c0c4c-02d2-424a-8ebe-e17ab8c4a6e8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001844.5(COL2A1):c.1833+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/866602"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/55c08b86-fe80-40ff-9823-b8fab9ce8b16","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55c08b86-fe80-40ff-9823-b8fab9ce8b16_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8737653","allele":{"id":"https://genegraph.clinicalgenome.org/r/3dc93317-3ad0-4c20-b5d5-e9a53e4942cf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001844.5(COL2A1):c.1222-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/17374"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1dc66c3b-ac46-489f-a23e-134faa059bc0","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1dc66c3b-ac46-489f-a23e-134faa059bc0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31736238","allele":{"id":"https://genegraph.clinicalgenome.org/r/c2ce64b8-13f9-4bbe-9413-96cc9e47e980","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001844.5(COL2A1):c.1030C>T (p.Arg344Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/620125"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2dd057f1-9d70-48a5-904f-664ed1741d2b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2dd057f1-9d70-48a5-904f-664ed1741d2b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27408751","allele":{"id":"https://genegraph.clinicalgenome.org/r/10a3a199-2ae9-49b2-b25d-cc0472493abd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000012.12:g.47998202del (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573102925"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/bf5ce998-b66f-48c3-a7dd-e1ab57511b26","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf5ce998-b66f-48c3-a7dd-e1ab57511b26_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26626311","allele":{"id":"https://genegraph.clinicalgenome.org/r/d981339d-929e-4a77-b36f-89c39f4d4b0e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001844.5(COL2A1):c.647G>A (p.Gly216Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16619530"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/3eb9287e-d731-417e-a814-9630b47301a4_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3eb9287e-d731-417e-a814-9630b47301a4_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/067d4408-aaf7-43b0-92b0-358b7ebb5119","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bfaed38-3994-4c55-aea7-88d7ddfc358e","type":"Finding","dc:description":"Signal for in situ hybridization observed in the vitreous space, in the lens, the developing ganglion cell layer, region of developing ciliary body and iris, retinal pigment epithelium, internal limiting membrane of the retina, sclera, and cornea.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12525971","rdfs:label":"COL2A1 Expression in Eye","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7f35b761-55a2-42d8-bed3-c4875c371220","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea5fe40f-ba55-425f-9535-f1dc092c7e17","type":"Finding","dc:description":"In situ hybridization of fetal human tissues revealed COL2A1 expression in marrow cells, osteoblasts, fibroblasts and some osteocytes, in addition to chondrocytes in otic capsule.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7806485","rdfs:label":"COL2A1 Expression in Skeletal System","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0df036ea-20d2-4892-a804-d0e3a9f71a57","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4598c825-8d3e-42c9-bbdf-5438c375000e","type":"Finding","dc:description":"A cosmid containing the human type II collagen gene was introduced into embryonic stem cells in vitro. The transformed cells contribute to all tissues in chimeric mice allowing the expression of the exogenous gene to be studied in vivo. Human type II collagen mRNA is restricted to tissues showing transcription from the endogenous gene and human type II collagen is found in extracellular matrix surrounding chondrocytes in cartilage. The results indicate that the cis-acting requirements for correct temporal and spatial regulation of the gene are contained within the introduced DNA.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/3033664","rdfs:label":"Expression of COL2A1","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3eb9287e-d731-417e-a814-9630b47301a4_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c29207c-d833-4dc9-8176-14667690f3f1","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b85a1c4-b8a4-4812-8f38-2fc15c50f385","type":"Finding","dc:description":"A low content of type II collagen containing fibrils possibly makes the vitreous matrix more vulnerable to degenerative changes already at young age. This is in agreement with the observation of vitreoretinal degeneration and retinal detachment already in young patients with Stickler syndrome. The molecular mechanism of disease is also consistent with COL2A1 inactivation, leading to altered expression of structural matrix molecules also in the vitreous, including HA and proteoglycans. The density of the vitreous filaments was clearly reduced in the COL2A1 +/âˆ’ mice.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16546167","rdfs:label":"Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Definitive","sequence":10431,"specifiedBy":"GeneValidityCriteria9","strengthScore":15.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/xR7lviCVhEc","type":"GeneValidityProposition","disease":"obo:MONDO_0007160","gene":"hgnc:2200","modeOfInheritance":"obo:HP_0000006"},"version":"2.2","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3eb9287e-d731-417e-a814-9630b47301a4-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}